Background Limited research exists on screening thresholds for low-dose CT in detecting malignant pure ground-glass lung ...

Experts believe poor diet, more ultra-processed foods, obesity and a lack of exercise are playing a role. A long-awaited ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

The PD-L1 IHC 28-8 PharmDx test is used to provide information on PD-L1 expression as a biomarker for patient response to therapies containing anti-PD-1 antibodies.

Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic ...

HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients with pancreatic tumors were successfully treated in the company sponsored GANNON trial ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that it intends to offer and sell, subject ...

Feasibility Trial Evaluates Safety of Histotripsy to Destroy Pancreatic Tumors MINNEAPOLIS--BUSINESS WIRE--HistoSonics, the developer and ...

ImmunityBio (IBRX) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an ...

ImmunityBio, Inc. (IBRX), an immunotherapy company, on Wednesday priced its previously announced underwritten public offering of ...

Tumors and other cancers can shed DNA into the bloodstream, distorting the ratios. Sometimes this can lead to alarming ...